PHARM · Pharming Group N.V. · Financials
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Browse captured authority reports and their original financial labels
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| USD/shares | $0.00 | -$0.02 | -$0.02 | $0.02 | $0.03 | $0.06 | $0.07 |
| USD/shares | $0.00 | -$0.02 | -$0.02 | $0.02 | $0.02 | $0.06 | $0.06 |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current bonds issued, including current portion of noncurrent bonds | 2025-12-31 | USD 5,336,000 | 20-F/A filed 2026-04-13 |
| Lease liabilities | 2025-12-31 | USD 17,719,000 | 20-F/A filed 2026-04-13 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent bonds issued | 2025-12-31 | USD 92,719,000 | 20-F/A filed 2026-04-13 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| United States | $361,746,000 | $287,149,000 | $239,107,000 | $200,082,000 | $193,419,000 | $202,684,000 | $182,294,000 |
| Europe and Rest of the World | $14,388,000 | $10,051,000 | $6,209,000 | $5,540,000 | $4,933,000 | — | — |
| Rest of the World Excluding US and Europe | — | — | — | — | — | $1,258,000 | $1,447,000 |
| Europe | — | — | — | — | — | $8,232,000 | $5,648,000 |